INVOSSA

Serial Number 87980139
Registration 5829948
700

Registration Progress

Application Filed
Feb 7, 2018
Under Examination
Aug 21, 2018
Approved for Publication
Jun 26, 2018
Published for Opposition
Jun 26, 2018
Registered
Aug 6, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-08-06)
Due: Aug 06, 2025 29 days

Basic Information

Serial Number
87980139
Registration Number
5829948
Deadline
August 6, 2025
Description
5 Year - Section 8 and 15 Renewal
Filing Date
February 7, 2018
Registration Date
August 6, 2019
Published for Opposition
June 26, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 6, 2019
Registration
Registered
Classes
005

Rights Holder

Kolon TissueGene, Inc.

03
Address
Suite 300
9713 Key West Avenue
Rockville, MD 20850

Ownership History

TissueGene, Inc.

Original Applicant
03
Rockville, MD

TissueGene, Inc.

Owner at Publication
03
Rockville, MD

Kolon TissueGene, Inc.

New Owner After Publication #1
03
ROCKVILLE, MD

Kolon TissueGene, Inc.

Original Registrant
03
Rockville, MD

Legal Representation

Attorney
Maren C. Perry

USPTO Deadlines

Next Renewal Deadline
29 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-08-06)
Due Date
August 06, 2025
Grace Period Ends
February 06, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description
Aug 6, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 22, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 22, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 21, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 21, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 6, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 3, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 2, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 6, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 6, 2019 GNRT F NON-FINAL ACTION E-MAILED
Mar 6, 2019 CNRT W SU - NON-FINAL ACTION - WRITTEN
Mar 5, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Mar 5, 2019 DPCC D DIVISIONAL PROCESSING COMPLETE
Mar 5, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 5, 2019 IUAF S USE AMENDMENT FILED
Feb 5, 2019 DRRR I DIVISIONAL REQUEST RECEIVED
Feb 5, 2019 ERTD I TEAS REQUEST TO DIVIDE RECEIVED
Feb 5, 2019 EISU I TEAS STATEMENT OF USE RECEIVED
Aug 21, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 26, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 26, 2018 PUBO A PUBLISHED FOR OPPOSITION
Jun 6, 2018 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 6, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 22, 2018 DOCK D ASSIGNED TO EXAMINER
May 22, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 22, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of arthritis and orthopedic disorders
First Use Anywhere: Nov 19, 2018
First Use in Commerce: Nov 19, 2018

Classification

International Classes
005